| Serial Number | 88103626 |
| Word Mark | BICKI |
| Filing Date | Tuesday, September 4, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, September 10, 2019 |
| Registration Number | 5855074 |
| Registration Date | Tuesday, September 10, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 5, 2019 |
| Goods and Services | (Based on 44(e)) Pharmaceuticals for the treatment of cancer and autoimmune diseases; Sanitary preparations for medical purposes; Dietetic foods and beverages adapted for medical use; Medicines for human purposes, namely, medicines for treating cancer and autoimmune diseases; Chemical preparations for medical or pharmaceutical purposes, namely, treating cancer and autoimmune diseases; Vaccines; Serums; Chemical reagents for medical use; Disinfectants; Pharmaceutical preparations for the treatment of autoimmune diseases; Immunostimulants; Immunomodulators; Immunoassay reagents for medical use; Biological preparations for the treatment of cancer; Biological preparations for the treatment of cancer and autoimmune diseases; Monoclonal antibodies for use in disease testing |
| Goods and Services | (Based on 44(e)) Provision of medical services; Advice relating to immunology; Therapy services in the nature of therapeutic health care services |
| Goods and Services | (Based on 44(e)) Scientific and technological services, namely, research and design in the field of medicine and health; Design and development of software and data bases; Medical research; Research relating to biology and biotechnology; Pharmaceutical research services; Clinical research in the field of cancer and autoimmune diseases; Research and development services in the field of immunology; research and development in the field of microorganisms, cells and antibodies; Research and development of vaccines and medicines; biological analysis; Biological laboratory services; Advice on research and development in the field of therapeutics; Laboratory services relating to the production of monoclonal antibodies; Research and development services in the field of antibodies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 11, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 11, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 11, 2018 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | OSE Immunotherapeutics |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Nantes 44200 FR |
| Party Name | OSE Immunotherapeutics |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Nantes 44200 FR |
| Party Name | OSE Immunotherapeutics |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Nantes 44200 FR |
| Event Date | Event Description |
| Friday, December 28, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, September 7, 2018 | NEW APPLICATION ENTERED |
| Tuesday, September 11, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, December 14, 2018 | ASSIGNED TO EXAMINER |
| Saturday, December 15, 2018 | NON-FINAL ACTION WRITTEN |
| Saturday, December 15, 2018 | NON-FINAL ACTION E-MAILED |
| Saturday, December 15, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, December 20, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 27, 2018 | ASSIGNED TO LIE |
| Friday, December 28, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 28, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 16, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 5, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 5, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 2, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, August 7, 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, July 18, 2019 | TEAS DELETE 1(B) BASIS RECEIVED |
| Thursday, July 18, 2019 | NOTICE OF ALLOWANCE CANCELLED |
| Wednesday, August 7, 2019 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Tuesday, September 10, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 10, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |